The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results